|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | |
| C07D 401/14 | |||
| C07D 405/14 | |||
| C07D 413/14 | |||
| A61K 31/4439 | |||
| A61P 35/00 |
| (11) | Number of the document | 2303861 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09766150.8 |
| Date of filing the European patent application | 2009-06-15 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2009/050675 |
| Date | 2009-06-15 |
| (87) | Number | WO 2009/153589 |
| Date | 2009-12-23 |
| (30) | Number | Date | Country code |
| 73055 P | 2008-06-17 | US |
| (72) |
BARLAAM, Bernard, Christophe, FR
FOOTE, Kevin, Michael, GB
PLE, Patrick, FR
JONES, Clifford, David, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | PYRIDINE COMPOUNDS |
| PYRIDINE COMPOUNDS |